loading...

Rhinitis Control Assessment Test (RCAT)

Nathan RA; Dalal AA; Stanford RH; Meltzer EO; Schatz M; Derebery J; Mintz M; Thompson MA; DiBenedetti DB; GlaxoSmithKline Research and Development Limited (GSK)

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Published in 2010 and 2013

Authors

Nathan RA; Dalal AA; Stanford RH; Meltzer EO; Schatz M; Derebery J; Mintz M; Thompson MA; DiBenedetti DB; GlaxoSmithKline Research and Development Limited (GSK)

Copyright
Copyright ©2013 GlaxoSmithKline. All rights reserved.
Objective
To monitor the level of rhinitis symptom control
Therapeutic area
  • Otorhinolaryngologic Diseases
  • Respiratory Tract Diseases
  • Immune System Diseases
Therapeutic indication

Rhinitis, Allergic

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Nathan RA, Dalal AA, Stanford RH, Meltzer EO, Schatz M, Derebery J, Mintz M, Thompson MA, Dibenedetti DB. Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control.Patient. 2010 Jun 1;3(2):91-9 (PubMed abstract)

Nathan RA. The rhinitis control assessment test: implications for the present and future. Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):13-9 (PubMed abstract)

Meltzer EO, Schatz M, Nathan R, Garris C, Stanford RH, Kosinski M. Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis. J Allergy Clin Immunol. 2013 Feb;131(2):379-86 (PubMed abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Nathan RA; Dalal AA; Stanford RH; Meltzer EO; Schatz M; Derebery J; Mintz M; Thompson MA; DiBenedetti DB; GlaxoSmithKline Research and Development Limited (GSK)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. 
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the USA

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

For information on, or permission to use the translations, please contact Mapi Research Trust

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us